143 related articles for article (PubMed ID: 28949511)
1. Microenvironmental Control of MUC1 Aptamer-Guided Acid-Labile Nanoconjugate within Injectable Microporous Hydrogels.
Xu C; Han X; Jiang Y; Yuan S; Wu Z; Wu Z; Qi X
Bioconjug Chem; 2017 Oct; 28(10):2530-2537. PubMed ID: 28949511
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
Dai B; Hu Y; Duan J; Yang XD
Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
[TBL] [Abstract][Full Text] [Related]
3. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
[TBL] [Abstract][Full Text] [Related]
4. Dendronized nanoconjugates of lysine and folate for treatment of cancer.
Jain K; Gupta U; Jain NK
Eur J Pharm Biopharm; 2014 Aug; 87(3):500-9. PubMed ID: 24698808
[TBL] [Abstract][Full Text] [Related]
5. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
6. One-Step Self-Assembly of Multifunctional DNA Nanohydrogels: An Enhanced and Harmless Strategy for Guiding Combined Antitumor Therapy.
Wei H; Zhao Z; Wang Y; Zou J; Lin Q; Duan Y
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46479-46489. PubMed ID: 31747745
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Bioconjugate for Cancer Cell-Targeted Theranostics.
Du W; Yuan Y; Wang L; Cui Y; Wang H; Xu H; Liang G
Bioconjug Chem; 2015 Dec; 26(12):2571-8. PubMed ID: 26580576
[TBL] [Abstract][Full Text] [Related]
8. In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase.
Si H; Wang L; Li Q; Li X; Li L; Tang B
Chem Commun (Camb); 2018 Jul; 54(59):8277-8280. PubMed ID: 29989641
[TBL] [Abstract][Full Text] [Related]
9. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
Zhou T; Li J; Jia X; Zhao X; Liu P
Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
[TBL] [Abstract][Full Text] [Related]
11. Injectable and thermoresponsive self-assembled nanocomposite hydrogel for long-term anticancer drug delivery.
Chen YY; Wu HC; Sun JS; Dong GC; Wang TW
Langmuir; 2013 Mar; 29(11):3721-9. PubMed ID: 23441993
[TBL] [Abstract][Full Text] [Related]
12. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
[TBL] [Abstract][Full Text] [Related]
13. Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study.
Hyun H; Park MH; Lim W; Kim SY; Jo D; Jung JS; Jo G; Um S; Lee DW; Yang DH
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):874-882. PubMed ID: 29749265
[TBL] [Abstract][Full Text] [Related]
14. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
Liu X; Wu L; Wang L; Jiang W
Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
[TBL] [Abstract][Full Text] [Related]
15. Injectable Hydrogel of Vitamin B
Panja A; Das S; Chakraborty A; Chakraborty P; Pal S; Nandi AK
ChemMedChem; 2018 Nov; 13(22):2427-2436. PubMed ID: 30222248
[TBL] [Abstract][Full Text] [Related]
16. Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells.
Joshi M; Choi JS; Park JW; Doh KO
J Microbiol Biotechnol; 2019 Nov; 29(11):1799-1805. PubMed ID: 31546295
[TBL] [Abstract][Full Text] [Related]
17. Modified chitosan thermosensitive hydrogel enables sustained and efficient anti-tumor therapy via intratumoral injection.
Jiang Y; Meng X; Wu Z; Qi X
Carbohydr Polym; 2016 Jun; 144():245-53. PubMed ID: 27083815
[TBL] [Abstract][Full Text] [Related]
18. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
19. Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro.
Hu Y; Duan J; Zhan Q; Wang F; Lu X; Yang XD
PLoS One; 2012; 7(2):e31970. PubMed ID: 22384115
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive carboxymethyl chitosan hydrogels via acid-labile ortho ester linkage as an implantable drug delivery system.
Gao J; Xu Y; Zheng Y; Wang X; Li S; Yan G; Wang J; Tang R
Carbohydr Polym; 2019 Dec; 225():115237. PubMed ID: 31521291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
